Our findings support the need to revisit the use of measuring Hb concentration in women of reproductive age to predict later risk of adverse outcomes, and more research is needed in settings with a greater burden of anemia and iron deficiency as we support programs and policies to expand maternal anemia reduction programs to the adolescent and preconception periods. The gene discussed is GSTM1; the disease is anemia.